Newronika
deep brain stimulation company
Newronika has raised €15M across 2 funding rounds from 10 investors, most recently a Series B round in Feb 2025. Based in Milan, Italy; active in Healthtech. Data as of 4 Nov 2026.
Milan, Italywww.newronika.it ↗
Total raised
€15M
€15,300,000
Funding rounds
2
Investors
10
distinct backers
Active since
2016-06
latest 2025-02
Funding by year
EUR raised per yearNewronika — funding by year — interactive chart.
Data table
| Newronika — funding by year | |
|---|---|
| 2016 | €1.7M |
| 2025 | €14M |
Signals
High confidenceRaise-next likelihood72
base rate 48% for Series B
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ 10y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-13 | Series B | €14M | Enea Tech Foundation,F3F,Indaco Venture Partners,Innogest Capital,TNBT Capital,Wille Finance | View deal → |
| 2016-06-01 | Seed | €1.7M | Atlante Ventures,Atlas Venture,Innogest Capital,Intesa Sanpaolo | View deal → |
Investors
10Related news
Similar companies
same sector, similar size- Kither Biotech€19MItaly · Healthtech
- Cellply€16MItaly · Healthtech
- Serenis€12MItaly · Healthtech
- Resalis Therapeutics€20MItaly · Healthtech
- Tensive€21MItaly · Healthtech
- Unobravo€17MItaly · Healthtech
Global coverage: FundingData